(Q45918352)

17 December 2017

title

Impact of metabolic syndrome and C-reactive protein on outcome after coronary stenting. (English)

1 reference

17 December 2017

1 reference

G R Iturry-Yamamoto

1

1 reference

17 December 2017

A C Zago

2

1 reference

17 December 2017

E H Moriguchi

3

1 reference

17 December 2017

W C Manfroi

4

1 reference

17 December 2017

J L Camargo

5

1 reference

17 December 2017

J L Gross

6

1 reference

17 December 2017

A J Zago

7

1 reference

17 December 2017

publication date

1 April 2009

1 reference

17 December 2017

Journal of Endocrinological Investigation

published in

1 reference

17 December 2017

volume

32

1 reference

17 December 2017

issue

4

1 reference

17 December 2017

page(s)

383-386

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1007/bf03345730

exact match

0 references

cites work

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1007%2FBF03345730

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345730

Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345730

Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345730

Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345730

Metabolic syndrome and risk of restenosis in patients undergoing percutaneous coronary intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345730

Impact of the metabolic syndrome on angiographic and clinical events after coronary intervention using bare-metal or sirolimus-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345730

Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345730

The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345730

Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345730

Predictive factors for ischemic target vessel revascularization in the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345730

Effect of lipid levels and lipid-lowering therapy on restenosis after coronary artery stenting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345730

Obesity and clinical restenosis after coronary stent placement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345730

Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345730

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345730

Abdominal and total adiposity and risk of coronary heart disease in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345730

Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345730

Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345730

Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03345730

Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement

21 January 2018

1 reference

12 December 2020

Influence of lesion length on restenosis after coronary stent placement

1 reference

12 December 2020

The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation

1 reference

12 December 2020

Clinical and angiographic determinants of adverse cardiac events in patients with stent restenosis

1 reference

12 December 2020

The impact of body mass index on short- and long-term outcomes inpatients undergoing coronary revascularization. Insights from the bypass angioplasty revascularization investigation (BARI)

1 reference

12 December 2020

Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials

1 reference

12 December 2020

Metabolic syndrome: risk factor distribution and 18-year mortality in the multiple risk factor intervention trial

1 reference

12 December 2020

Predictive factors of restenosis after coronary stent placement

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03345730

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017